Tower Research Capital LLC (TRC) - PHOENIX BIOTECH ACQUISITION ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$1,988
+8.6%
1750.0%0.00%
Q2 2023$1,830
+91400.0%
1750.0%0.00%
Q1 2023$20.0%1750.0%0.00%
Q4 2022$2
-99.9%
1750.0%0.00%
Q3 2022$2,0000.0%1750.0%0.00%
Q2 2022$2,0000.0%1750.0%0.00%
Q1 2022$2,0000.0%1750.0%0.00%
Q4 2021$2,0001750.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2023
NameSharesValueWeighting ↓
DIFESA CAPITAL MANAGEMENT, LP 125,000$1,259,0000.72%
Wealthspring Capital LLC 210,780$2,118,0000.40%
Castle Creek Arbitrage, LLC 400,000$4,027,0000.22%
Shaolin Capital Management LLC 750,000$7,551,0000.18%
Yakira Capital Management, Inc. 100,000$1,008,0000.16%
Schechter Investment Advisors, LLC 151,400$1,522,0000.15%
Spartan Fund Management Inc. 50,000$503,0000.11%
Silver Rock Financial LP 46,243$465,0000.10%
BASSO CAPITAL MANAGEMENT, L.P. 74,961$755,0000.08%
Sage Mountain Advisors LLC 35,610$358,0000.06%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders